Risk Factors of Immune-ChEckpoint Inhibitors MEdiated Liver, Gastrointestinal, Endocrine and Skin Toxicity
Clinical trial NCT04631731 · UNKNOWN
Trial details
- NCT number
- NCT04631731
- Sponsor
- Western Sydney Local Health District
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-15
- Primary completion
- 2024-12-10
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.